Armata Pharmaceuticals, Inc. (ARMP)
5.77
+0.10
(+1.76%)
USD |
NYAM |
Dec 11, 16:00
5.89
+0.12
(+2.08%)
After-Hours: 20:00
Armata Pharmaceuticals Cash from Investing (Quarterly): -0.242M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Agenus, Inc. | 0.076M |
| Integer Holdings Corp. | -20.27M |
| Liquidia Corp. | -0.911M |
| AIM ImmunoTech, Inc. | 0.296M |
| Protalix Biotherapeutics, Inc. | -0.504M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.298M |
| Cash from Financing (Quarterly) | 14.97M |
| Free Cash Flow | -27.43M |
| Free Cash Flow Per Share (Quarterly) | -0.1253 |
| Free Cash Flow to Equity (Quarterly) | -38.27M |
| Free Cash Flow to Firm (Quarterly) | -0.194M |
| Free Cash Flow Yield | -11.34% |